BAIVF
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
Feb 14 closing price
Capitalization
16.12M
PLRX
Price
$1.56
Change
+$0.03 (+1.95%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
96.38M
17 days until earnings call
Ad is loading...

BAIVF vs PLRX

Header iconBAIVF vs PLRX Comparison
Open Charts BAIVF vs PLRXBanner chart's image
BENEVOLENTAI
Price$0.22
Change-$0.00 (-0.00%)
Volume$500
Capitalization16.12M
Pliant Therapeutics
Price$1.56
Change+$0.03 (+1.95%)
Volume$5.06K
Capitalization96.38M
BAIVF vs PLRX Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAIVF vs. PLRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAIVF is a Hold and PLRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BAIVF: $0.22 vs. PLRX: $1.53)
Brand notoriety: BAIVF and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BAIVF: 100% vs. PLRX: 33%
Market capitalization -- BAIVF: $16.12M vs. PLRX: $96.38M
BAIVF [@Biotechnology] is valued at $16.12M. PLRX’s [@Biotechnology] market capitalization is $96.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAIVF’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • BAIVF’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, BAIVF is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 4 TA indicator(s) are bullish.

  • PLRX’s TA Score: 4 bullish, 3 bearish.

Price Growth

BAIVF (@Biotechnology) experienced а 0.00% price change this week, while PLRX (@Biotechnology) price change was +6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

PLRX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($96.4M) has a higher market cap than BAIVF($16.1M). BAIVF YTD gains are higher at: -47.619 vs. PLRX (-88.079).
BAIVFPLRXBAIVF / PLRX
Capitalization16.1M96.4M17%
EBITDAN/A-205.16M-
Gain YTD-47.619-88.07954%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A356M-
Total DebtN/A60.2M-
TECHNICAL ANALYSIS
Technical Analysis
PLRX
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA250.7412.77
+5.37%
Tesla
AAPL204.604.86
+2.43%
Apple
SPY535.428.17
+1.55%
SPDR® S&P 500® ETF
BTC.X93699.110000257.210940
+0.28%
Bitcoin cryptocurrency
GME27.12-0.68
-2.45%
GameStop Corp

BAIVF and

Correlation & Price change

A.I.dvisor tells us that BAIVF and BMEA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BAIVF and BMEA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAIVF
1D Price
Change %
BAIVF100%
N/A
BMEA - BAIVF
33%
Poorly correlated
+5.64%
RNXT - BAIVF
20%
Poorly correlated
+3.58%
CLYM - BAIVF
20%
Poorly correlated
+3.13%
RLYB - BAIVF
20%
Poorly correlated
+4.79%
PLRX - BAIVF
20%
Poorly correlated
+2.33%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+1.95%
LXRX - PLRX
42%
Loosely correlated
+4.70%
ITRM - PLRX
41%
Loosely correlated
-6.47%
SRRK - PLRX
41%
Loosely correlated
+5.72%
FHTX - PLRX
40%
Loosely correlated
-4.49%
CRGX - PLRX
37%
Loosely correlated
-0.55%
More